Company news
Cambium Bio Ltd news in 2025
Cambium Bio Ltd's news releases, calls and decks from 2025, newest first.
Cambium Bio Signs Strategic MoU with Benta SAS
September 5, 2025
Cambium Bio Signs US$2.0M plus Licensing Deal
September 2, 2025
FY25 Appendix 4E and Annual Report
August 29, 2025
Placement Participant Update
August 27, 2025
Cambium Bio Raises A$2.12 million
July 30, 2025
Half Year Report (December 2024)Cambium Bio Limited Half Year Report (December 2024) (Feb 27, 2025Feb 27, 2025)
February 27, 2025
FDA Approves Elate Ocular Phase 3 Clinical Trial Protocol
February 24, 2025